---
figid: PMC6006503__ol-16-01-0041-g00
figtitle: Role and molecular pathway of IL-32 in cancer
organisms:
- NA
pmcid: PMC6006503
filename: ol-16-01-0041-g00.jpg
figlink: /pmc/articles/PMC6006503/figure/f1-ol-0-0-8649/
number: F1
caption: 'The role and molecular pathway of IL-32 in cancer. IL-32 activates 3 pathways:
  The P38-MAPK, NF-κB/STAT-3 and PI3K/Akt pathways. The activation of these pathways
  modifies the expression of several genes that affect cell proliferation, survival,
  migration and invasion, and carcinogenic angiogenesis and inflammation, causing
  tumorigenic effects. IL, interleukin; MAPK, mitogen-activated protein kinase; NF-κB,
  nuclear factor-κB; Bcl, B-cell lymphoma; Mcl-1, induced myeloid leukemia cell differentiation
  protein 1; XIAP, x-linked inhibitor of apoptosis; PUMA, p53 upregulated modulator
  of apoptosis; MMP, matrix metalloproteinase; VEGF, vascular endothelial growth factor;
  STAT, signal transducer and activator of transcription; PI3K, phosphoinositide 3-kinase;
  Akt, protein kinase B; HIF, hypoxia-inducible factor; TNF, tumour necrosis factor.'
papertitle: Role of interleukin-32 in cancer biology.
reftext: Haimeng Yan, et al. Oncol Lett. 2018 Jul;16(1):41-47.
year: '2018'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.6506822
figid_alias: PMC6006503__F1
figtype: Figure
organisms_ner:
- Danio rerio
- Homo sapiens
redirect_from: /figures/PMC6006503__F1
ndex: 660c009b-df0e-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6006503__ol-16-01-0041-g00.html
  '@type': Dataset
  description: 'The role and molecular pathway of IL-32 in cancer. IL-32 activates
    3 pathways: The P38-MAPK, NF-κB/STAT-3 and PI3K/Akt pathways. The activation of
    these pathways modifies the expression of several genes that affect cell proliferation,
    survival, migration and invasion, and carcinogenic angiogenesis and inflammation,
    causing tumorigenic effects. IL, interleukin; MAPK, mitogen-activated protein
    kinase; NF-κB, nuclear factor-κB; Bcl, B-cell lymphoma; Mcl-1, induced myeloid
    leukemia cell differentiation protein 1; XIAP, x-linked inhibitor of apoptosis;
    PUMA, p53 upregulated modulator of apoptosis; MMP, matrix metalloproteinase; VEGF,
    vascular endothelial growth factor; STAT, signal transducer and activator of transcription;
    PI3K, phosphoinositide 3-kinase; Akt, protein kinase B; HIF, hypoxia-inducible
    factor; TNF, tumour necrosis factor.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - tp53
  - mapk14a
  - chmp2a
  - bcl2a
  - xiap
  - mmp2
  - cxcl8a
  - vegfaa
  - ctnnb1
  - stat3
  - mmp9
  - il10
  - il6
  - il1b
  - tnfb
  - NFKB1
  - TP53
  - TP63
  - TP73
  - CRK
  - MAPK14
  - MAPK1
  - AIMP2
  - GRAP2
  - AHSA1
  - POLDIP2
  - MAPK11
  - MAPK12
  - MAPK13
  - MAPK3
  - MAPK8
  - MAPK9
  - MAPK10
  - BCL2
  - CHMP2A
  - MCL1
  - XIAP
  - BBC3
  - MMP2
  - CXCL8
  - VEGFA
  - VEGFB
  - VEGFC
  - VEGFD
  - PGF
  - HIF1A
  - EPAS1
  - HIF3A
  - ARNT
  - ARNT2
  - BMAL1
  - CTNNB1
  - IL32
  - STAT3
  - MMP9
  - AKT1
  - AKT2
  - AKT3
  - IL10
  - IL6
  - IL1B
  - TNF
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - XIAP
---
